Alera Partners is a global healthcare focused investment management firm specializing in the biotechnology, pharmaceuticals and medical technology sectors. Alera’s flagship equity long/short fund employs an absolute return, low net strategy and targets low teen net uncorrelated returns with low volatility. The firm’s unique investment style pairs fundamental primary research with trading acumen and employs a disciplined, process oriented approach to both research and portfolio management.